Complex I inhibitor of oxidative phosphorylation in advanced solid tumors and acute myeloid leukemia: phase I trialsTimothy A. Yap, Marina Konopleva, Naval Daver et al.|Nature Medicine|2023Cited by 372
Metastatic Pancreatic Cancer: ASCO Guideline UpdateDavendra Sohal, Daniel A. Laheru, Erin B. Kennedy et al.|Journal of Clinical Oncology|2020Cited by 287
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b studyJames J. Harding, Sebastián Mondaca, Lequn Bao et al.|The Lancet Oncology|2023Cited by 243
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trialShubham Pant, Eileen M. O’Reilly, Zev A. Wainberg et al.|Nature Medicine|2024Cited by 234
Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic CancerJulien Dilly, Brian M. Wolpin, Andrew J. Aguirre et al.|Cancer Discovery|2024Cited by 234